These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1161 related articles for article (PubMed ID: 33737877)

  • 1. Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile.
    Vatsalya V; Li F; Frimodig J; Gala KS; Srivastava S; Kong M; Ramchandani VA; Feng W; Zhang X; McClain CJ
    Front Pharmacol; 2020; 11():598128. PubMed ID: 33737877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Prospects for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-vitro Evidence and Pharmacokinetic Profile.
    Vatsalya V; Li F; Frimodig JC; Gala KS; Srivastava S; Kong M; Ramchandani VA; Feng W; Zhang X; McClain CJ
    medRxiv; 2020 Aug; ():. PubMed ID: 32869036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the optimum thiamine dose to treat or prevent Wernicke's encephalopathy or Wernicke-Korsakoff syndrome? Results of a randomized controlled trial.
    Dingwall KM; Delima JF; Binks P; Batey R; Bowden SC
    Alcohol Clin Exp Res; 2022 Jun; 46(6):1133-1147. PubMed ID: 35428992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal demise and Wernicke-Korsakoff syndrome in a patient with hyperemesis gravidarum: a case report.
    Olmsted A; DeSimone A; Lopez-Pastrana J; Becker M
    J Med Case Rep; 2023 Feb; 17(1):32. PubMed ID: 36726136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wernicke-Korsakoff syndrome despite no alcohol abuse: A summary of systematic reports.
    Oudman E; Wijnia JW; Oey MJ; van Dam M; Postma A
    J Neurol Sci; 2021 Jul; 426():117482. PubMed ID: 34000679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encephalopathy responsive to thiamine in severe COVID-19 patients.
    Branco de Oliveira MV; Irikura S; Lourenço FHB; Shinsato M; Irikura TCDB; Irikura RB; Albuquerque TVC; Shinsato VN; Orsatti VN; Fontanelli AM; Samegima DAG; Gonçalves MVM; Bernabé DG
    Brain Behav Immun Health; 2021 Jul; 14():100252. PubMed ID: 33817670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse.
    Day E; Bentham P; Callaghan R; Kuruvilla T; George S
    Cochrane Database Syst Rev; 2004; (1):CD004033. PubMed ID: 14974055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine Drizzle-The Rationale for Abandoning "Cytokine Storm".
    Stolarski AE; Kim J; Zhang Q; Remick DG
    Shock; 2021 Nov; 56(5):667-672. PubMed ID: 34652339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fighting the storm: could novel anti-TNFα and anti-IL-6
    Kovalchuk A; Wang B; Li D; Rodriguez-Juarez R; Ilnytskyy S; Kovalchuk I; Kovalchuk O
    Aging (Albany NY); 2021 Jan; 13(2):1571-1590. PubMed ID: 33465050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol.
    Day E; Bentham PW; Callaghan R; Kuruvilla T; George S
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD004033. PubMed ID: 23818100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders.
    Latt N; Dore G
    Intern Med J; 2014 Sep; 44(9):911-5. PubMed ID: 25201422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study.
    Pathak Y; Mishra A; Choudhir G; Kumar A; Tripathi V
    Pharmacol Rep; 2021 Jun; 73(3):926-938. PubMed ID: 33970450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Clinician's View of Wernicke-Korsakoff Syndrome.
    Wijnia JW
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose thiamine strategy in Wernicke-Korsakoff syndrome and related thiamine deficiency conditions associated with alcohol use disorder.
    Praharaj SK; Munoli RN; Shenoy S; Udupa ST; Thomas LS
    Indian J Psychiatry; 2021; 63(2):121-126. PubMed ID: 34194054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
    Wang J; Jiang M; Chen X; Montaner LJ
    J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte transketolase activity in the Wernicke-Korsakoff syndrome.
    Leigh D; McBurney A; McIlwain H
    Br J Psychiatry; 1981 Aug; 139():153-6. PubMed ID: 7306754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine storm and translating IL-6 biology into effective treatments for COVID-19.
    Li T; Wang D; Wei H; Xu X
    Front Med; 2023 Dec; 17(6):1080-1095. PubMed ID: 38157195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CytoResc - "CytoSorb" Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial.
    Stockmann H; Keller T; Büttner S; Jörres A; Kindgen-Milles D; Kunz JV; Leebmann J; Spies C; Träger K; Treskatsch S; Uhrig A; Willam C; Enghard P; Slowinski T;
    Trials; 2020 Jun; 21(1):577. PubMed ID: 32586396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.